Connection

Allen Kaplan to Female

Back to Details
This is a "connection" page, showing publications Allen Kaplan has written about Female.
Allen Kaplan
Connection Strength
0.354
Female
  1. Vibratory Urticaria and ADGRE2. N Engl J Med. 2016 07 07; 375(1):94-5.
    View in: PubMed
    Score: 0.028
  2. Timing and duration of omalizumab response in patients with chronic idiopathic/spontaneous urticaria. J Allergy Clin Immunol. 2016 Feb; 137(2):474-81.
    View in: PubMed
    Score: 0.027
  3. Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels. J Allergy Clin Immunol. 2016 06; 137(6):1822-1829.e1.
    View in: PubMed
    Score: 0.027
  4. Omalizumab in patients with symptomatic chronic idiopathic/spontaneous urticaria despite standard combination therapy. J Allergy Clin Immunol. 2013 Jul; 132(1):101-9.
    View in: PubMed
    Score: 0.023
  5. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II. J Allergy Clin Immunol. 2013 Aug; 132(2):470-5.
    View in: PubMed
    Score: 0.023
  6. Omalizumab is effective in nonautoimmune urticaria. J Allergy Clin Immunol. 2011 May; 127(5):1300-2.
    View in: PubMed
    Score: 0.020
  7. Treatment of chronic autoimmune urticaria with omalizumab. J Allergy Clin Immunol. 2008 Sep; 122(3):569-73.
    View in: PubMed
    Score: 0.016
  8. Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study. Ann Allergy Asthma Immunol. 2005 Jun; 94(6):662-9.
    View in: PubMed
    Score: 0.013
  9. IL3 effect on basophils histamine release upon stimulation with chronic urticaria sera. Allergy. 2003 Aug; 58(8):802-7.
    View in: PubMed
    Score: 0.012
  10. TH1/TH2 cytokines and inflammatory cells in skin biopsy specimens from patients with chronic idiopathic urticaria: comparison with the allergen-induced late-phase cutaneous reaction. J Allergy Clin Immunol. 2002 Apr; 109(4):694-700.
    View in: PubMed
    Score: 0.011
  11. The international WAO/EAACI guideline for the management of hereditary angioedema-The 2021 revision and update. Allergy. 2022 07; 77(7):1961-1990.
    View in: PubMed
    Score: 0.010
  12. Clinical practice. Chronic urticaria and angioedema. N Engl J Med. 2002 Jan 17; 346(3):175-9.
    View in: PubMed
    Score: 0.010
  13. Analysis of cold activation of the contact system in hereditary angioedema with normal C1 inhibitor. Mol Immunol. 2021 08; 136:150-160.
    View in: PubMed
    Score: 0.010
  14. A Comparative Study of Sex Distribution, Autoimmunity, Blood, and Inflammatory Parameters in Chronic Spontaneous Urticaria with Angioedema and Chronic Histaminergic Angioedema. J Allergy Clin Immunol Pract. 2021 06; 9(6):2284-2292.
    View in: PubMed
    Score: 0.010
  15. The XTEND-CIU study: Long-term use of omalizumab in chronic idiopathic urticaria. J Allergy Clin Immunol. 2018 03; 141(3):1138-1139.e7.
    View in: PubMed
    Score: 0.008
  16. Omalizumab substantially improves dermatology-related quality of life in patients with chronic spontaneous urticaria. J Eur Acad Dermatol Venereol. 2017 Oct; 31(10):1715-1721.
    View in: PubMed
    Score: 0.008
  17. Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studies. Ann Allergy Asthma Immunol. 2016 10; 117(4):370-377.e1.
    View in: PubMed
    Score: 0.007
  18. Rapid oral desensitization to sirolimus in a patient with lymphangioleiomyomatosis. J Allergy Clin Immunol Pract. 2016 Mar-Apr; 4(2):352-3.
    View in: PubMed
    Score: 0.007
  19. Similar Efficacy with Omalizumab in Chronic Idiopathic/Spontaneous Urticaria Despite Different Background Therapy. J Allergy Clin Immunol Pract. 2015 Sep-Oct; 3(5):743-50.e1.
    View in: PubMed
    Score: 0.007
  20. Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria. N Engl J Med. 2013 Mar 07; 368(10):924-35.
    View in: PubMed
    Score: 0.006
  21. Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment. PLoS One. 2013; 8(2):e53773.
    View in: PubMed
    Score: 0.006
  22. A randomized, placebo-controlled, dose-ranging study of single-dose omalizumab in patients with H1-antihistamine-refractory chronic idiopathic urticaria. J Allergy Clin Immunol. 2011 Sep; 128(3):567-73.e1.
    View in: PubMed
    Score: 0.005
  23. Safety and tolerability of the direct renin inhibitor aliskiren in combination with angiotensin receptor blockers and thiazide diuretics: a pooled analysis of clinical experience of 12,942 patients. J Clin Hypertens (Greenwich). 2011 Jul; 13(7):506-16.
    View in: PubMed
    Score: 0.005
  24. Safety and tolerability of the direct renin inhibitor aliskiren: a pooled analysis of clinical experience in more than 12,000 patients with hypertension. J Clin Hypertens (Greenwich). 2010 Oct; 12(10):765-75.
    View in: PubMed
    Score: 0.005
  25. Development of a daily diary for patients with chronic idiopathic urticaria. Ann Allergy Asthma Immunol. 2010 Aug; 105(2):142-8.
    View in: PubMed
    Score: 0.005
  26. Activation of plasma Hageman factor and kallikrein in ongoing allergic reactions in the skin. J Immunol. 1987 Oct 15; 139(8):2744-8.
    View in: PubMed
    Score: 0.004
  27. Studies of the cellular infiltrate of chronic idiopathic urticaria: prominence of T-lymphocytes, monocytes, and mast cells. J Allergy Clin Immunol. 1986 Nov; 78(5 Pt 1):914-8.
    View in: PubMed
    Score: 0.004
  28. Alterations in eotaxin, monocyte chemoattractant protein-4, interleukin-5, and interleukin-13 after systemic steroid treatment for nasal polyps. Otolaryngol Head Neck Surg. 2004 Nov; 131(5):585-9.
    View in: PubMed
    Score: 0.003
  29. Eucalyptus as a specific irritant causing vocal cord dysfunction. Ann Allergy Asthma Immunol. 2004 Sep; 93(3):299-303.
    View in: PubMed
    Score: 0.003
  30. Immunoreactive tissue kallikrein in human serum. J Lab Clin Med. 1984 May; 103(5):731-8.
    View in: PubMed
    Score: 0.003
  31. Unusual cold-induced disorders: cold-dependent dermatographism and systemic cold urticaria. J Allergy Clin Immunol. 1984 Apr; 73(4):453-6.
    View in: PubMed
    Score: 0.003
  32. Chronic urticaria. Possible causes, suggested treatment alternatives. Postgrad Med. 1983 Sep; 74(3):209-15, 218-22.
    View in: PubMed
    Score: 0.003
  33. Histologic studies of chronic idiopathic urticaria. J Allergy Clin Immunol. 1983 Feb; 71(2):177-83.
    View in: PubMed
    Score: 0.003
  34. Identification of a new physically induced urticaria: cold-induced cholinergic urticaria. J Allergy Clin Immunol. 1981 Dec; 68(6):438-41.
    View in: PubMed
    Score: 0.003
  35. Idiopathic cold urticaria: in vitro demonstration of histamine release upon challenge of skin biopsies. N Engl J Med. 1981 Oct 29; 305(18):1074-7.
    View in: PubMed
    Score: 0.003
  36. Exercise-induced anaphylaxis as a manifestation of cholinergic urticaria. J Allergy Clin Immunol. 1981 Oct; 68(4):319-24.
    View in: PubMed
    Score: 0.003
  37. Late asthmatic reactions provoked by intradermal injection of T-cell peptide epitopes are not associated with bronchial mucosal infiltration of eosinophils or T(H)2-type cells or with elevated concentrations of histamine or eicosanoids in bronchoalveolar fluid. J Allergy Clin Immunol. 2001 Sep; 108(3):394-401.
    View in: PubMed
    Score: 0.003
  38. Histamine release and therapy of severe dermatographism. J Allergy Clin Immunol. 1981 Aug; 68(2):103-5.
    View in: PubMed
    Score: 0.003
  39. The role of cyproheptadine in the treatment of cold urticaria. J Allergy Clin Immunol. 1980 Apr; 65(4):309-12.
    View in: PubMed
    Score: 0.002
  40. A double-blind, placebo-controlled trial of fexofenadine HCl in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol. 1999 Nov; 104(5):1071-8.
    View in: PubMed
    Score: 0.002
  41. Pattern of nasal secretions during experimental influenza virus infection. Rhinology. 1996 Mar; 34(1):2-8.
    View in: PubMed
    Score: 0.002
  42. Williams trait. Human kininogen deficiency with diminished levels of plasminogen proactivator and prekallikrein associated with abnormalities of the Hageman factor-dependent pathways. J Clin Invest. 1975 Dec; 56(6):1650-62.
    View in: PubMed
    Score: 0.002
  43. The kallikrein-kinin system in inflammation. Adv Exp Med Biol. 1989; 247A:125-36.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.